Page last updated: 2024-08-24

aromasil and Hypophosphatemia

aromasil has been researched along with Hypophosphatemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Iwata, H; Kimura, R; Lee, MJ; Masuda, N; Nishimura, Y; Saji, S; Sawaki, M; Shimomura, A; Tamura, K; Trepel, J; Yasojima, H; Yuno, A	1

Trials

1 trial(s) available for aromasil and Hypophosphatemia

Article	Year
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer. BMC cancer, 2021, Nov-24, Volume: 21, Issue:1 Topics: Acetylation; Aged; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Female; Histone Deacetylase Inhibitors; Humans; Hypophosphatemia; Japan; Lymphocyte Activation; Middle Aged; Nausea; Platelet Count; Progression-Free Survival; Pyridines	2021

Article

Year

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.

BMC cancer, 2021, Nov-24, Volume: 21, Issue:1

Topics: Acetylation; Aged; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Female; Histone Deacetylase Inhibitors; Humans; Hypophosphatemia; Japan; Lymphocyte Activation; Middle Aged; Nausea; Platelet Count; Progression-Free Survival; Pyridines

2021